纳入研究 | 年份 | 样本量(例) | 性别(男/女) | 年龄(岁) | 胸腺瘤数(例) | 肿瘤大小(cm) | 结局指标 | |||||
S | I | S | I | S | I | S | I | S | I | |||
DC Cao | 2018 | 22 | 25 | 12/10 | 15/10 | 58.4 | 58.4 | 10 | 11 | NA | NA | F1; F2; F3; F4; F5 |
HW Cui | 2018 | 36 | 36 | 21/25 | 13/23 | 46.7 | 45.3 | 36 | 36 | 2.51 | 2.43 | F1; F2; F3; F4; F5; F6 |
NM Bao | 2020 | 45 | 42 | 26/19 | 24/18 | 44.37 | 44.08 | 45 | 42 | 2.79 | 2.83 | F1; F2; F4; F5; F6 |
HG Chen | 2020 | 34 | 32 | 19/15 | 18/14 | 49.62 | 48.28 | 53 | 3.11 | 2.98 | F1; F2; F3; F5; F6; F7 | |
Xing Jin | 2020 | 36 | 36 | 20/16 | 19/17 | 52.2 | 51.8 | NA | NA | NA | NA | F2; F3; F5 |
SH Lin | 2020 | 45 | 45 | 27/18 | 31/14 | 45.67 | 44.91 | 90 | NA | NA | F1; F2; F4; F5; F6; F7 | |
LJ Wang | 2020 | 40 | 40 | 27/13 | 24/16 | 44.45 | 45.10 | 80 | 2.55 | 2.59 | F1; F2; F3; F4; F5; F6; F7 | |
ZH Xie | 2020 | 25 | 25 | 14/11 | 10/15 | 51.2 | 52.6 | 50 | 2.8 | 2.5 | F1; F2; F3; F5; F6; F7 | |
YW Zheng | 2020 | 28 | 28 | 16/12 | 19/9 | 45.17 | 44.98 | NA | NA | NA | NA | F1; F2; F3; F4; F5; F7 |
JH Chu | 2021 | 105 | 105 | 57/48 | 66/39 | 48.47 | 48.26 | NA | NA | 2.26 | 2.12 | F1; F2; F3; F4; F5; F7 |
Wei Li | 2021 | 40 | 40 | 24/16 | 22/18 | 51.26 | 51.03 | NA | NA | 5.60 | 5.66 | F1; F2; F5; F6; F7 |
JZ Pang | 2021 | 40 | 40 | 18/22 | 16/24 | 52.2 | 53.9 | 14 | 11 | 4.45 | 4.31 | F1; F2; F3; F4; F5; F6; F7 |
Kai Wu | 2021 | 45 | 45 | 24/21 | 26/19 | 45.98 | 46.52 | 14 | 10 | 2.07 | 2.08 | F1; F2; F3; F5; F6; F7 |
JJ Xu | 2021 | 20 | 20 | 13/7 | 11/9 | 44.2 | 45.7 | 40 | NA | NA | F1; F2; F3; F4; F6; F7 | |
Ming Li | 2021 | 67 | 66 | 36/31 | 34/32 | 44.37 | 44.26 | NA | NA | 2.84 | 2.80 | F1; F3; F6; F7 |
Wei Liang | 2021 | 40 | 40 | 26/14 | 24/16 | 57.3 | 56.3 | 80 | NA | NA | F1; F2; F3; F4; F5; F6 |